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Abstract
Chemoattractants regulate diverse immunological, developmental, and pathological processes, but
how cell migration patterns are shaped by attractant production in tissues remains incompletely
understood. Using computational modeling and chemokine-releasing microspheres (CRMs), cell-
sized attractant-releasing beads, we analyzed leukocyte migration in physiologic gradients of
CCL21 or CCL19 produced by beads embedded in 3D collagen gels. Individual T-cells that
migrated into contact with CRMs exhibited characteristic highly directional migration to attractant
sources independent of their starting position in the gradient (and thus independent of initial
gradient strength experienced) but the fraction of responding cells was highly sensitive to position
in the gradient. These responses were consistent with modeling calculations assuming a threshold
absolute difference in receptor occupancy across individual cells of ~10 receptors required to
stimulate chemotaxis. In sustained gradients eliciting low receptor desensitization, attracted T-
cells or dendritic cells swarmed around isolated CRMs for hours. With increasing CRM density,
overlapping gradients and high attractant concentrations caused a transition from local swarming
to transient “hopping” of cells bead to bead. Thus, diverse migration responses observed in vivo
may be determined by chemoattractant source density and secretion rate, which govern receptor
occupancy patterns in nearby cells.
Introduction
Cell motility and guided tissue trafficking are fundamental to diverse processes in
development, pathology, homeostasis of the immune system, and responses to infection.1–5
Host chemokines play a particularly critical role in trafficking of immune cells, by
regulating leukocyte interactions with endothelial cells and entry/exit from tissues,6,7
compartmentalization within lymphoid organs,8 and promoting chemotactic (directional) or
chemokinetic (random) motility.9–12 Chemoattractant molecules can also be derived from
pathogens themselves, promoting recruitment of leukocytes to sites of infection.13 Within
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tissues, chemoattractants produced by local cells can diffuse in soluble form and/or bind to
the surrounding extracellular matrix, leading to soluble or matrix-bound chemokine fields in
the surrounding tissue environment.14–16 Concentration gradients of such attractants provide
spatial cues guiding chemotactic or haptotactic cell migration. The importance of host
chemokines to proper functioning of immunity is reflected in the substantial defects in
lymphoid organ development17 and responses to infectious challenge18 observed in animals
genetically deficient in one or more chemoattractants or their receptors. These key roles for
chemotaxis in immune function have also motivated interest in potentially engineering
chemoattractant responses in vivo for therapeutic ends.19–21
Chemoattractants stimulate diverse cellular migration responses in vivo. Intravital and
whole-tissue explant imaging studies have shown that abundant ligands for the chemokine
receptor CCR7 stimulate T-cell motility in lymph nodes,22,23 but migration paths in the
lymph node appear largely random, guided by haptokinetic interactions with the chemokine-
decorated stromal reticular network.16,24 Directional migration can also be stimulated by
chemoattractants in vivo, as has been directly observed for lymph node B-cells migrating
toward the T-cell area during immune responses,10 CD8+ T-cell recruitment to antigen-
specific CD4+ T-cell/dendritic cell (DC) pairs in lymph nodes,12 or neutrophils chemotaxing
through tissue to sites of Leishmania infection.25 “Swarming” behaviours of T-cells
aggregating around antigen presenting cells in lymph nodes26,27 and neutrophils aggregating
around parasite-infected cells in skin25 or lymph nodes28 have also been described, which
likely involve host- or pathogen-derived attractant signals. However, because the nature of
the chemoattractant concentration fields in live tissues in vivo is typically unknown, the
mechanisms by which chemoattractant production, diffusion, matrix binding, and receptor
stimulation integrate to elicit such a diversity of responses remain poorly understood.
Few studies have directly visualized chemotactic migration of T-cells or dendritic cells
under conditions where the attractant gradient is known/well defined. Current theoretical
and experimental evidence suggests that mammalian cell chemotaxis is elicited in the
presence of chemoattractant gradients as cells detect ΔRc, the difference in the number of
chemokine-receptor complexes induced at the front vs. rear of the cell.29–31 Strikingly, the
threshold value of ΔRc required for leukocytes to sense a gradient has been estimated to be
as small as ~10 receptors over the length of a cell,30,32 and very shallow attractant gradients
stimulate chemotaxis.30,33 Recently, microfluidic devices have been developed that permit
the generation of stable, linear or near-linear one-dimensional concentration gradients of
chemoattractants, in order to expose cells within mm-scale 2D or 3D migration chambers to
well-defined attractant stimuli.34–36 These studies have shown that lymphocytes and DCs
are responsive to extremely shallow gradients, and have revealed hierarchies in
responsiveness for leukocytes exposed simultaneously to competing gradients.33,36,37
However, the concentration gradient of attractants formed in proximity to an isolated
secreting cell38,39 or collection of cells21 is highly nonlinear, with rapid decay in
concentration with distance from the secreting source(s). Thus, cells migrating toward a
chemokine-releasing cell face both increasing attractant concentration and increasing
gradient steepness. Increasing concentrations may suppress the cells’ ability to respond to
the gradient through receptor saturation and/or desensitization, while increasing gradient
steepness should promote increased directionality to chemotactic migration by increasing
the gradient in receptor engagement across the cell body. These two competing effects make
it unclear how leukocytes will respond as they approach secreting cells generating
physiologically-steep attractant gradients, and whether chemokine signalling alone can
promote migration of leukocytes into contact with target secreting cells or temporally-stable
retention of cells at a location in space. Microfluidic devices are not well suited to address
these problems as they typically create one-dimensional gradients, and do not capture the
“point source” nature of individual secreting cells or clusters of cells.
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To address these fundamental questions, we employed a reductionist in vitro experimental
system combined with computational modeling to mimic the production of chemoattractants
in tissue and characterize the response of human leukocytes to well-defined locally-
produced gradients. We recently designed synthetic hydrogel microspheres with sizes on the
order of single cells, which can be loaded with chemokines and release these attractants over
a period of many hours at physiologic rates, mimicking secretion by single cells.40 Here, we
embedded these chemokine-releasing microspheres (CRMs) in 3D extracellular matrix gels
with human T-cells or DCs, and quantitatively analyzed dynamics of cells responding to
gradients of two different chemokines involved in lymphocyte and DC trafficking/
homeostasis, CCL19 and CCL21. We found that T-cells migrating into contact with nearby
CRMs exhibited highly directional migration independent of their starting position within
the attractant gradient, but position in the gradient determined the fraction of T-cells
recruited into this responding population. Strikingly, under conditions of low receptor
desensitization, stable stimulatory gradients stimulated long-lived swarming of T-cells or
DCs around individual attractant-releasing beads. However, high densities of attractant
sources, where the ambient attractant concentration is high and neighboring gradients
overlap, led to short-lived attraction toward individual sources and biased “hopping” of cells
between attractant sources. Together, these results provide substantial insight into how
diverse migration responses can be elicited by a single chemokine, depending on the
conditions of attractant production in a local tissue.
Results
Physiologic chemokine secretion rates create concentration profiles of CCL19 and CCL21
that stimulate substantial receptor occupancy gradients
To gain a theoretical picture of how chemokine secretion translates into chemoattractant
receptor occupancy gradients that direct leukocyte migration, we first modelled the secretion
of CCL21 by isolated “source” cells secreting chemokine at a constant rate, and determined
the steady-state profile of receptor occupancy for CCR7-expressing cells exposed to this
attractant gradient. These initial calculations were made assuming no matrix binding of the
chemokine, and considering clearance mechanisms (proteolytic degradation, consumption
by non-responding cells, etc.) via a lumped first-order degradation rate constant estimated
from experimental measurements of chemokine degradation by serum proteases41–45 (see
Supplementary Methods for detailed transport equations and Table S1, ESI, for summary of
model parameters). As illustrated in Fig. S1A, ESI, in the absence of matrix binding, the
concentration gradient developed around individual secreting cells releasing chemokine at
rates in the physiological range estimated for lymphatic endothelial cells and mature
dendritic cells46–49 reaches steady state within minutes, and thus we subsequently focused
on calculation of steady-state gradient characteristics.
The concentration of attractant at a given distance from the source cell determines the
fractional occupancy of chemokine receptors on responding CCR7-expressing cells at that
location, Rc/RT (number of attractant-complexed receptors divided by total number of cell
surface receptors). The attractant concentration change over the length of a responding cell
in turn generates a difference in number of occupied receptors between the front and rear of
the cell, the receptor occupancy gradientΔRc. Both Rc/RT and ΔRc have been shown to
impact cell migration induced by chemoattractant concentration gradients.30,33,36 Combined
modelling and experimental measurements of ΔRc have suggested that a threshold difference
in receptor occupancy of ~10 receptors is required for leukocytes to sense and respond to
attractant gradients.29,30 Notably, CCR7 is known to be resistant to desensitization by
CCL21, which triggers minimal receptor downregulation and elicits sustained stimulation of
T-cells, even following hours of exposure to substantial concentrations of ligand.11,23,50
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Thus, we calculated the chemokine concentration profiles and receptor occupancy gradients
of responding cells expressing 104 non-desensitizable CCR7 receptors in the vicinity of a
source cell secreting CCL2146–48 (Fig. 1A–B and Fig. S1B, ESI). The secretion rate directly
determined both rstim, the maximum distance a functional gradient extended from the cell
(assuming a threshold of ΔRc > 10 receptors over a 10 μm cell body for chemotaxis, Fig.
1C), and the peak strength of the gradient (i.e., maximum ΔRc and Rc/RT). Variation of the
rate of chemokine clearance rate over a 25-fold range or the number of receptors expressed
per cell over a 6-fold range led to modest changes in the predicted receptor occupancy
difference generated on responding cells but did not alter the qualitative characteristics of
the receptor engagement profiles predicted (data not shown). These calculations lead to
several predictions about chemotactic responses in tissues: (1) Receptor saturation is not
expected to occur for a responding cell exposed to any of these physiologic chemokine
secretion rates, even in close proximity to the secreting cell (Fig. S1B, ESI); (2) higher
chemokine secretion rates increase rstim, but this parameter asymptotically approaches a
plateau peak value above ~0.5 pg/hr/cell, which limits the maximum distance from the
secreting cell that a chemotactic response can be elicited (< 200 μm); and (3) the strength of
the chemotactic response (determined by ΔRc) should increase as responding cells approach
the secreting cell, irrespective of the secretion rate.
The qualitative features of these predicted attractant and receptor occupancy profiles remain
true if more complex physiologic situations are assumed, though the quantitative details are
altered. For example, CCL21 can bind to proteoglycans in the extracellular matrix and on
cell surfaces.9,15,51,52 If secreted chemokine binds to matrix, gradients with qualitatively
similar features are formed (irrespective of whether only free soluble attractant is active,
only matrix-bound attractant is active, or both soluble and matrix-bound attractant are
active, Fig. S1C, ESI).
Also critical to the chemotactic response is the role of receptor internalization and
desensitization. Here it is interesting to contrast the two ligands for CCR7: CCL19 and
CCL21 bind to CCR7 with comparable affinities (both with estimated KDs of several
nM,53–55 but unlike CCL21, CCL19 triggers rapid internalization of CCR7 and
desensitization of CCR7 signalling.50,56,57 We thus next assessed the impact of receptor
downregulation and desensitization on the response of leukocytes to a local secreting cell.
Using a simple model of ligand-induced receptor desensitization developed by Lin and
Butcher58 (see Supplementary Text, ESI) and desensitization parameters obtained by fitting
our own experimental measurements of CCR7 downregulation by CCL19 (Fig. S2, ESI), we
calculated the expected receptor occupancy and ΔRc induced around CCL19-secreting cells.
As shown in Fig. 1D, CCL19 in general elicits weaker peak receptor occupancy gradients
compared to CCL21 at a given secretion rate. At high CCL19 secretion rates characteristic
of dendritic cells,48 these calculations predict receptor desensitization by CCL19 will lead to
a substantially weaker receptor occupancy gradient near the secreting cell compared to an
equivalent gradient of CCL21 (~25-fold lower ΔRc for CCL19 gradients near the source
cell).
Chemoattractants are often produced by collections of cells in tissues (e.g., CCL21 produced
by stromal cells of inflamed lungs59 and skin60 or lymphoid tissues17,22,23), and thus we
next determined the attractant/CCR7 occupancy gradients that would develop around
individual CCL21-secreting cells in a field of uniformly-spaced secreting cells (Fig. 2A),
assuming reversible binding of chemokine to matrix, as a function of the density of secreting
cells in the tissue. As shown in Fig. 2B, as the density of attractant-secreting cells increases,
the steady-state concentration of chemokine and the net fraction of occupied receptors on
nearby responding cells increases. In turn, the functional range of the chemokine gradient
around each secreting cell contracts as the source cell density increases, irrespective of
Wang and Irvine Page 4













whether soluble (Fig. 2C, D), matrix-bound, or both soluble and matrix-bound attractant (not
shown) is active. High steady-state concentrations of CCL21 (~150 nM) comparable to the
levels experimentally measured in lymph nodes61–63 are expected for secreting cell densities
of ~50 μm between sources. However, even in this setting of dense source cells, the
calculations predict locally functional receptor occupancy gradients would exist at short
distances (a few cell diameters) around each secreting cell for non-desensitizing binding of
CCL21 to CCR7. Thus, responding leukocytes should be capable of sensing local gradients
around individual attractant-secreting cells even when high densities of secreting cells are
present in a tissue.
Differences in receptor desensitization lead to distinct responsiveness of lymphocytes to
CCL21 vs. CCL19 gradients
We next designed an experimental system to mimic CCR7 ligand production in tissue in
order to test whether the simple receptor binding/desensitization models employed above
correctly predict human leukocyte stimulation by local CCL21 and CCL19 gradients, and to
determine the relationship between the magnitude of ΔRc and actual migration responses.
We prepared chemokine-releasing microspheres (CRMs), cell-sized synthetic
polysaccharide microspheres that release chemoattractants at tunable rates, to create cell-
mimetic CCL19 and CCL21 gradients in vitro. CRMs were composed of the polysaccharide
alginate, which was loaded with chemokines by adsorption, mimicking the reversible
binding of chemokines to polysaccharides in ECM (Fig. S3A–C, ESI).40 Because
fluorophore-conjugated CCL19 and CCL21 were active at concentrations (<5 nM) well
below the limits detectable by our fluorescence microscopes (~16 nM), direct visualization
of gradients by fluorescence imaging was not possible. Instead, we measured rates of
attractant release from collections of microspheres in suspension and used this data
combined with the measured size distribution of the microspheres to calculate the expected
attractant diffusion profile around individual beads.40 Though CRMs release embedded
chemokine by diffusion of the attractant from the alginate matrix (leading to a decaying
release rate with time), the quantity of loaded attractant directly determined the initial
release rate and allowed gradients to be generated that modeling predicts are qualitatively
very similar to the gradients generated by isolated secreting cells (Fig. S3D–F, ESI).
However, the lack of chemokine clearance in this in vitro model leads to slow decay of ΔRc
over a period of hours as chemokine builds up in the matrix (Fig. S4, ESI). CCL21-releasing
CRMs (CCL21-CRMs) were predicted to drive steadily increasing receptor occupancy
gradients with increasing initial release rate, while for CCL19-CRMs, modeling predicted
that lack of attractant clearance would elicit pronounced receptor desensitization at higher
release rates, giving short-lived gradients and a peak in ΔRc at intermediate release rates
(Fig. 3A, D).
To quantify resting human T-cell responses to these gradients, we measured mean velocities
of the cells (vmean) and a hit rate ratio, Kon/Konrand measured over 30 min in collagen (Figs.
3B–C, E–F). The hit rate was defined after Castellino et al.12 as the number of T-cells
migrating into contact with an individual CRM per unit time normalized by the total number
of cells in the imaging volume (Ntot): Kon = number of contacts/time•Ntot. By taking a ratio
of Kon to the theoretical hit rate for lymphocytes encountering CRMs by chance during
random migration through the matrix, Konrand (see Supplemental Text, ESI), we obtained a
convenient measure of the degree of directional migration, with Kon/Konrand > 1 indicating
biased migration toward the chemokine sources.
Consistent with the slightly greater sensitivity of human T-cells to CCL19 compared to
CCL21,50 CCL21-CRMs did not stimulate migration speeds above the basal level of resting
T-cells alone in collagen for initial release rates less than ~0.2 pg/hr/bead, while CCL19-
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CRMs stimulated migration even at the lowest release rate tested (initial rate 0.01 pg/hr/
bead, Fig. 3C). Though migration speeds of T-cells plateaued at ~8 μm/min for higher
chemokine release rates in the presence of both CCL19-and CCL21-CRMs, the hit rate
ratios showed distinct patterns of chemotactic responses to CCR7 ligand gradients:
increasing rates of CCL21 release triggered increasing hit rates of T-cells migrating to
nearby beads (Fig. 3B), while the hit rate ratio of T-cells migrating toward CCL19-CRMs
peaked at the intermediate chemoattractant release rate of ~0.05 pg/hr/particle (Fig. 3E). As
a control, T-cells embedded in collagen with “empty” CRMs in the presence of uniform
concentrations of soluble CCL21 or CCL19 migrated with similar velocities but showed a
hit rate ratio that was not significantly different from 1, indicating random migration (Fig.
3B–C, E). As expected, T-cell migration toward the attractant sources was dependent on G
protein-coupled receptor signalling and CCR7, as treatment of cells with pertussis toxin or
blocking anti-CCR7 antibodies dropped the hit rate ratio to ~1 (Fig. S5, ESI). Strikingly, for
each chemokine, the magnitude of ΔRc was strongly correlated with the magnitude of
chemotaxis detected (compare Figs. 3A, 3B and Figs. 3D, 3E). Notably, the peak
chemotactic responses elicited by optimal CCL19 gradients and CCL21 were comparable,
but CCL19 gradients stimulated this peak response at ~10-fold lower ΔRc values (Fig. 3F),
which may reflect the more sensitive engagement of downstream signals by CCL19. These
findings suggest that the strength of chemotactic responses to both CCL19 and CCL21
gradients are linked to the magnitude of receptor occupancy differences generated across
responding lymphocytes, but that on a per-engaged receptor basis, CCL19 engagement of
CCR7 more sensitively drives chemotaxis than CCL21.
Individual T-cells recruited by local gradients are highly chemotactic, with increasing
gradient steepness increases the fraction of responding cells
As shown in Fig. 1, the gradient generated by isolated cells secreting chemokine at a
constant rate is characterized by a temporally stable but spatially-varying concentration and
gradient steepness – both the absolute concentration and the relative slope of the
concentration profile increase as the separation between the responding cell and source
decrease. Using CRMs to approximate this idealized tissue model, we next analysed single-
cell migration responses over 1.5 hr as a function of position in the gradient around single
CCL21-CRMs (initial release rates 0.7 pg CCL21/bead/hr) or control beadssurrounded by
uniform fields of CCL21. From these imaging data, we calculated the approach angle (angle
between the cell’s displacement vector and a vector from the cell to the bead), instantaneous
chemotaxis index (ICI, distance travelled toward the bead divided by total distance moved in
a single time interval), turning angle (angle between subsequent displacement vectors in two
sequential time steps), and velocity of each cell at each time-point. When resting T-cells
were imaged in collagen in the presence of empty beads and 10 μg/mL soluble CCL21 to
stimulate random migration, migration paths of the cells followed persistent random walks
distributed around the bead (Fig. 4A and Video S1). By contrast, resting T-cells in the
vicinity of CCL21-CRMs chemotaxed from distances up to 200 μm directly into contact
with the surfaces of the attractant-releasing beads, with many cells exhibiting highly
directional migration paths (Fig. 4A and Video S2). For T-cells responding to CCL21-
CRMs, mean values determined for all cell/time-point measurements collected at a given
distance from the chemokine source over the 1.5 hr imaging window showed that T-cell
velocities and turning angles were only weakly dependent on a cell’s position within the
gradient, but the mean approach angle steadily decreased and mean ICI increased as the
distance to the source decreased (Fig. 4A). Our gradient calculations predicted that for this
CCL21 release rate, cells up to ~150 μm away from individual beads would be stimulated to
chemotax (Fig. 3C), based on the modelled gradient evolution around individual beads and
the calculated receptor occupancy expected from the known KD of CCL21-CCR7 binding.
Although this is only a very indirect estimate, this maximum stimulation distance matched
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the experimental ICI data well, suggesting that the threshold requirement of ΔRc≥ 10
receptors for chemotactic responses assumed in the calculations is reasonably accurate. We
also analysed the migration response of activated human T-cells, to determine whether
primed T-cells with high constitutive motility exhibit similar chemotactic responses to
CCL21 at the single-cell level. Human T-cells activated in vitro with PHA and IL-2 retained
CCR7 expression identical to resting T-cells (not shown). Interestingly, activated T-cells
responded more strongly than resting cells to CCL21 gradients, with higher ICI values and
lower approach angles achieved at all positions in the local gradient (Fig. 4A).
We were struck by the nearly linear paths followed by many of the T-cells migrating into
contact with CCL21-releasing CRMs, some of which began at distances of a more than 100
μm away from the attractant source (Fig. S6, ESI). To better understand this chemotactic
response, we calculated the mean percentage of time that individual cells were “highly
chemotactic” (HC), defined as the percentage of time-steps where an individual cell had an
ICI > 0.5, as a function of their starting position in the gradient. Cells migrating in uniform
fields of CCL21 near empty CRMs showed a mean % time HC of ~0.36 (not statistically
different from the expected mean value of 0.33 for completely random migration), and this
mean value did not vary to significantly with starting distance from the bead (Fig. 4B). In
contrast, T-cells migrating in the vicinity of CCL21-CRMs showed a steadily increasing %
time HC as their starting distance from the bead decreased; cells within 50 μm of the bead at
the start were highly chemotactic for 80% of the observation period. Notably, when this
analysis was performed specifically on attracted T-cells (those cells that migrated into
contact with the attractant source during the experiment), attracted cells showed a % time
HC of 0.75–0.8 independent of their starting distance from the CRM (Fig. 4B dashed line).
However, the fraction of attracted cells among all T-cells starting at a given distance from
the attractant source increased as the starting separation from the bead decreased (Fig. 4C).
These results indicate that attracted cells are made up of a population that commits strongly
to the gradient independent of their starting position (and therefore, independent of the
magnitude of their initial receptor occupancy gradient); increasing gradient steepness near to
the source does not increase the chemotactic prowess of individual recruited T-cells, but
does increase the fraction of T-cells that join this highly chemotactic population. Further
work will be needed to determine the source of the increasing responding population with
increasing gradient strength; this might reflect selective recruitment of T-cells with the
highest levels of CCR7 expression at low gradient strength with cells expressing lower
levels of receptor engaged by stronger gradients.
Persistent localized gradients of CCL21 induce swarming of attracted leukocytes
Although chemotactic cell migration is commonly assayed over short durations of 30–60
minutes,64 leukocytes are exposed to persistent attractant sources in vivo (e.g., lymphatic
endothelial cells and lymphoid stromal cells constitutively producing CCR7 ligands8,65),
which could stimulate cells over much longer durations. We thus next asked how the
migration response of lymphocytes to persistent CCR7 ligand gradients evolves over time,
by imaging resting T-cell migration for 6 hrs near isolated CRMs loaded with 7.5 μg
CCL21/mg alginate, a loading calculated to produce functional gradients of CCL21 for
many hours (Fig. S4A, ESI). Strikingly, within 90 min of mixing T-cells and CCL21-
releasing CRMs in collagen, the strong chemotactic response led the vast majority of cells to
accumulate around the nearest attractant microsphere (Fig. 5A), leading to ~80% of cells in
a given field of view to be accumulated around beads by the end of 90 min. This
accumulation reflected persistent “swarming” of attracted lymphocytes around individual
CRMs, where cells that reached a CCL21-releasing bead maintained a high velocity but
their direction remained pinned at the bead surface over many hours (Fig. 5B and Video S3,
ESI). Swarming required a gradient of attractant, as no accumulation was observed when
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cells were mixed with beads in uniform concentrations of CCL21 or when attractant was
absent (Fig. 5B and data not shown). By labelling a fraction of the cells, we could follow
individual cells swarming at beads and found that the mean retention time of individual T-
cells around a CCL21-releasing CRM was ~3 hrs, though strikingly, a population of
lymphocytes (~10%) were attracted to beads and remained localized at a single attractant
source for the duration of the imaging experiment (6 hrs, Fig. 5C). Those T-cells that did
begin migrating away from the surface of a CCL21-releasing bead were efficiently
“recaptured” by the gradient, with ~80% of cells that began migrating away from the
attractant source (against the gradient) over the first 3 hrs turning and migrating back to the
bead surface, reaching a median distance from the bead of only ~50 μm before returning to
the nearby CCL21 source (Fig. 5D–E).
As expected from the gradient and receptor desensitization calculations, in contrast to
CCL21, CRM-generated CCL19 gradients were completely unable to support sustained
accumulation of lymphocytes (Video S4, ESI). Using CRMs releasing CCL19 at rates that
elicited the peak chemotactic response in short term assays (1 μg CCL19 loaded per mg
alginate), T-cells were observed to transiently chemotax toward CCL19 sources over ~30
min, but then migrated away in random directions at later times (Fig. 5A), and though T-cell
motility remained high, a significant “trapped” population failed to develop around CCL19-
releasing CRMs (Fig. 5B–D). Similar results with even weaker initial chemotaxis were
observed at higher and lower CCL19 release rates (not shown).
To determine if the ability of CCL21 gradients to support localized swarming was specific
to T-cells or rather a general property of CCL21-CCR7 signalling, we also characterized the
migration response of CCR7-expressing LPS-matured human monocyte-derived dendritic
cells to both gradients. As shown in Fig. S7 and Video S5, ESI, human DCs expressing
CCR7 exhibited stable accumulation and swarming around CCL21 gradient-generating
CRMs.). Altogether, these data suggest that sustained chemokine secretion is capable of
promoting both prolonged attraction of responding leukocytes and dramatic confinement of
attracted cells near the attractant source, provided that receptor desensitization and the
steady-state gradient properties permit an above-threshold ΔRc to be maintained over time.
Ambient chemokine concentration regulates T-cell chemotaxis through changes in
receptor occupancy gradients
The model calculations and results above indicate that isolated persistent chemoattractant
sources can elicit very localized sequestration of lymphocytes in the absence of chemokine
receptor desensitization. However, as the ambient steady-state concentration of
chemoattractant increases in the local microenvironment, the increase in overall receptor
occupancy will stimulate chemokinesis in competition with directional migration responses.
To determine the impact of the absolute level of chemokine in the local environment on
chemotactic responses induced by local gradients, we systematically varied total chemokine
levels by adding increasing concentrations of free CCL21 to the collagen matrix along with
CCL21-releasing beads. We first calculated the expected gradient around CCL21-CRMs as
a function of increasing levels of free attractant pre-existing in the matrix. As illustrated in
Fig. 6A and Fig. S8A–C, ESI, at any given timepoint as the background concentration of
free attractant increases, receptor occupancy increases at all points in the gradient, and the
receptor occupancy gradientΔRc steadily decreases. However, the calculations predict that
for ambient concentrations of free CCL21 up to 10 nM (100 ng/mL), ~2-fold above the KD
of CCL21-CCR7 binding, T-cells should still be capable of chemotaxing when they come
within ~50 μm of a CCL21-releasing bead for several hours (Fig. 6A; Fig. S8C, ESI).
Experimentally, resting T-cells mixed with CCL21-CRMs together with varying
concentrations of free CCL21 showed similar velocities irrespective of the level of free
Wang and Irvine Page 8













CCL21 present (Fig. S8D, ESI). However, the hit rate ratio for T-cells encountering CRMs
dropped monotonically as the concentration of free CCL21 increased, reaching the hit rate
expected for completely random migration at 1 μg/mL background CCL21 (Fig. 6B).
Analysis of the ICI of T-cells migrating near CCL21-releasing beads over a 30 min period
showed a contraction in both the maximum distance from an CRM where chemotaxis was
triggered and the magnitude of the chemotactic index achieved as the concentration of free
attractant in the matrix increased (Fig. 6C): Chemotaxis was detected within 50 μm of
CCL21-CRMs in the presence of 100 ng/mL free CCL21, but no attraction was detected for
1 μg/mL free CCL21. Analysis of the fraction of T-cells trapped by CRM gradients showed
that T-cell swarming persisted in the presence of low levels of background attractant (10 ng/
mL free CCL21), but the fraction of cells localized at the bead surfaces dropped as the
ambient CCL21 concentration was increased (Fig. 6D–E). Interestingly, activated T-cells
responded to CCL21 concentration gradients more sensitively than resting T-cells, retaining
persistent (> 60 min) swarming responses to CRM-generated gradients in the presence of
25-fold higher background CCL21 levels (Fig. 6E). Thus, T-cells can detect local gradients
of CCL21 produced by nearby cells even in the presence of substantial background levels of
free attractant in the local microenvironment.
Overlapping CCL21 gradients trigger a transition from “swarming” around isolated
attractant sources to “hopping” between local gradients
Our calculations of gradient formation suggest that even in tissues with high densities of
secreting cells (such as primary and secondary lymphoid organs), local gradients around
individual source cells should lead to chemotaxis-inducing receptor occupancy differences
in nearby lymphocytes (Fig. 2). However, as the density of attractant-secreting cells in a
tissue increases, the sharp gradients produced within 100–200 μm of individual cells will
begin to overlap. At such high densities of attractant-secreting cells (as expected for
example in lymph nodes), lymphocytes migrating even a few cell diameters away from one
source will detect the increasing gradient from another nearby source, which might lead to
transient, sequential chemotactic responses as cells move from source to source.
Alternatively, high overall receptor occupancy achieved in this setting might elicit an
overwhelming chemokinetic signal triggering unbiased, random migration. To determine
which of these situations prevails, we varied the mean separation between CCL21-releasing
CRMs dispersed stochastically in collagen. Using CCL21-CRMs that triggered peak
chemotaxis for isolated beads (7.5 μg CCL21 loaded per mg alginate), we measured the
response of T-cells to several different densities of CCL21 sources, starting from a
maximum separation of 500 μm between sources.
As before, we first calculated the expected concentration profiles and receptor occupancy
profiles as a function of the separation distance between beads. Over short times of 30–60
min, CRMs as close as 100 μm apart were predicted to induce stimulatory ΔRc values in
responding cells, but only within a few cell diameters of the source (Fig. S9, ESI),
qualitatively similar to the situation predicted for dense chemokine sources in tissue (Fig. 2).
We next imaged T-cells mixed in collagen with dense CCL21-releasing CRMs, limiting the
imaging time to the first 60 min, as buildup of chemokine in our in vitro model system was
predicted to cause rapid decay of ΔRc over a period of several hours (Fig. S9, ESI). As
shown in Fig. 7A, hit rate ratios measured for T-cells in the presence of CCL21-releasing
CRMs were highest when beads were separated by the largest distances, and ambient
chemokine concentration and overlap between neighboring gradients was lowest. Kon/
Konrand was statistically greater than 1 even for the closest bead separation tested (70 μm
average distance between CRMs). However, as expected from our “ambient” chemokine
experiments, T-cells did not exhibit prolonged swarming around individual attractant
sources, as the retention time of T-cells around individual CRMs was only ~15 min for
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beads separated by 200 μm and decayed to only ~5 min for CRMs separated by 70 μm (Fig.
7B). Rather, resting T-cells interspersed transient migration near individual beads with
biased paths hopping bead to bead (Fig. 7C). The combination of biased migration near
CRMs with short retention times around any single chemokine source led to a substantial
increase in the number of sources “visited” by individual T-cells in a given interval of time
as the CRM density increased (Fig. 7D). Thus, the ability of T-cells to transiently respond to
local gradients in chemokine-rich tissues may provide an effective mechanism to increase
the scanning of cells for antigen.
Finally, we also compared the migration behavior of PHA+IL-2-activated T-cells in this
dense-source setting. Strikingly, activated T-cells show a much greater sensitivity to the
short range gradients formed around individual CCL21-CRMs at high density in the
collagen matrix. As shown in Fig. 8A and Video S6, ESI, Even CCL21-CRMs separated by
only a few cell diameters accumulated their own “private” clusters of swarming T-cells,
which showed a much lower frequency of hopping among beads compared to resting T-
cells. This is illustrated by the plots of the fraction of trapped T-cells in Fig. 8B, where each
CRM is shown to stably trap a fraction of the surrounding T-cells, in a manner which is
sustained over > 2 hr. Thus, even in the setting of dense attractant point sources as might be
expected in lymphoid organs, activated T-cells show distinct chemoattraction behavior
compared to naïve/resting T-cells that could have functional consequences in vivo.
Discussion
Here we have used a reductionist model for chemokine production in tissue combined with
computational analyses to systemically study how qualitative and quantitative features of
chemokine gradients generated by attractant-secreting cells influence leukocyte migration at
the single-cell level. We focused on responses triggered by signalling through the CCR7
chemokine receptor, in part because of the importance of CCR7 signalling in guiding
leukocyte migration into and within primary and secondary lymphoid organs,66,67 and also
because the two ligands for CCR7, CCL19 and CCL21, exhibit distinct intracellular
signalling and receptor desensitization responses despite similar binding affinities,50,56,57,68
providing an experimental test-bed to ask how chemotactic responses elicited by the same
receptor are altered by the presence or absence of strong desensitization.
Prior experimental studies of chemotaxis using classical Dunn chambers or more recently
developed microfluidic devices designed to expose cells to well-defined chemoattractant
gradients have estimated that neutrophils exhibit directional migration in response to
minimum receptor occupancy differences of ~10 receptors over the length of the cell.30,32
This threshold appears to also hold for human T-cells responding to CCL21 and CCL19
gradients, as our experimental data was well described by gradient modelling employing this
minimum value of ΔRc as a threshold for chemotactic responses. Using this threshold for
functional responses, our computational analysis predicted maximum stimulatory distances
for chemotactic responses to isolated secreting cells of ~150 μm, in good agreement with the
experimental data and similar to calculated maximum distances of paracrine communication
predicted for individual cytokine-producing cells in tissue.38 Interestingly however, we
found that the relationship between the input signal (ΔRc) and the output response
(chemotaxis) differed for CCL19 and CCL21 gradients, with CCL19 stimulating equivalent
chemotactic responses at 10-fold weaker ΔRc inputs. This may reflect enhanced downstream
signalling induced by CCL19, which is much more potent at inducing phosphorylation of
ERK1/2 than CCL21.57
Although rates of T-cells migrating into contact with chemoattractant-releasing beads were
directly correlated with the magnitude of the receptor occupancy gradient induced in nearby
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cells, we found that interestingly, those cells that migrated into contact with the attractant
sources characteristically exhibited highly-directed migration, irrespective of their initial
position in the gradient. Increasing hit rates with increasing gradient strength reflected an
increasing fraction of T-cells recruited into this highly chemotactic population.
Though in many traditional in vitro assays (e.g., modified Boyden-chamber experiments)
CCL19 and CCL21 elicit similar chemotaxis from T-cells, we show here in this more
physiologic model of localized gradient formation that these two ligands for CCR7 can elicit
extremely different biological responses. T-cells were only transiently responsive to CCL19
and quickly lost directionality in CRM-generated gradients, irrespective of the chemokine
release rate employed (Fig. 5 and data not shown). In contrast, CCL21-CRMs were capable
of stimulating sustained swarming of T-cells around individual sources, localizing the
position of the cells within a roughly 100 μm-diameter space for many hours provided the
release rate was sufficient to generate a stimulatory gradient (Fig. 5). These results are
consistent with predictions from our simple models of CCL19 and CCL21 signalling, which
predicted pronounced receptor desensitization by CCL19 but sustained receptor occupancy
gradients in responding T-cells migrating within CCL21 gradients. These findings add to
previously reported differences in the ability of CCL19 and CCL21 to stimulate dendritic
cell chemotaxis due to differences in matrix binding, observed in microfluidic devices.33 We
also found sustained chemoattraction of activated T-cells toward CRMs with another
chemokine/receptor pair (CXCL10 binding CXCR3, data not shown), which exhibits
receptor desensitization intermediate between CCL19 and CCL21, suggesting such localized
swarming responses are not unique to CCL21 triggering of CCR7.
If above-threshold ΔRc values always induced chemotaxis and subsequent “trapping” as
shown above for isolated attractant sources, T-cells would be very inefficient at scanning
APCs in lymphoid microenvironments; this is counter to the known rapid scanning behavior
of T-cells in lymph nodes at steady state.69 However, attractant-secreting stromal cells are
present at high densities in secondary lymphoid organs, and steady-state chemokine levels of
2–10 μg/mL have been estimated in lymph nodes.61–63 Notably however, even in such
chemokine-rich environments, modelling predicts that chemokines eliciting low or no
desensitization (such as CCL21) will still induce a stimulatory receptor occupancy gradient
within a few cell diameters of individual secreting cells. Experimentally, this led to a
transition from swarming to “hopping” of resting T-cells between attractant sources as the
source density increased, with short residence times near individual attractant sources. Such
locally biased migration may be part of enhancing the efficiency of T-cell-DC encounters in
vivo. It is possible that biased organization of collagen fibers at the surface of individual
beads influences the migration paths of cells at the surface of beads, but these effects would
be the same in both the “swarming” and “hopping” experiments, and thus the attractant
gradients present appear to play a dominant role in the observed migration responses.
Interestingly, we found that activated T-cells showed an ability respond with highly
localized swarming around individual attractant sources even when CRMs were placed at
high density, indicating a high responsiveness to receptor occupancy gradients even when
the absolute fraction of engaged receptors is very high. Exploring the biochemical
mechanisms underlying this response is an area for future studies, but may have significant
implications for accumulation of primed T-cells at sites of infection or responses to localized
infections in lymph nodes.70
In summary, our studies provide evidence that human T-cells and dendritic cells exhibit
chemotactic responses to CCR7 ligands governed by a threshold requirement for receptor
occupancy differences of ~10 receptors over the length of the cells, in good agreement with
earlier estimates made for neutrophils.30,32 In the presence of local point sources,
chemotactic responses of T-cells are heavily influenced by the source density and receptor
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desensitization, with low receptor desensitization promoting prolonged residence times of
cells around individual sources. These findings indicate that attempts to engineer chemotaxis
for therapeutic ends (e.g., in vaccines, regenerative medicine, or cancer therapy) will likely
be most effective using chemokines such as CCL21 that trigger low levels of receptor
desensitization, to enable recruited cells to be stably accumulated at a target tissue site. The
data also suggest that diverse migration responses can be elicited from any given
chemokine/receptor pair depending on the quantitative details of gradient generation, and
explain how striking swarming behaviours observed in some settings in vivo can be achieved
even by soluble attractant gradients.
Materials and Methods
Modelling of chemokine gradient profiles
The concentration of chemokine (C) evolving around spherical source cells or beads 20 μm
in diam. releasing attractant were computationally modeled using commercial COMSOL
Multiphysics finite element modeling software (COMSOL Inc., Burlington, MA) and
solving the diffusion equation:
where D is the chemokine diffusion constant, Rp is the rate of chemokine clearance, and RM
accounts for reversible chemokine binding to the matrix (see Supplemental Text and Table
S1, ESI, for complete details and parameter values employed). Cells were modeled as
sources releasing attractant at a constant rate, while CRMs were modeled as releasing
attractant by diffusion through the alginate matrix starting from a constant initial
concentration of attractant within the microsphere at time zero. The diffusion constant for
chemokine diffusion through the alginate matrix of each bead was determined from
experimental measurements of chemokine release as previously described.40 Calculations
were performed assuming either periodic boundary conditions (mimicking a finite density of
secreting sources regularly arrayed in space, as in Fig. 2) or assuming isolated sources in an
infinite space (Fig. 1 calculations). Receptor occupancy gradients were calculated from the
attractant concentration profiles by assuming equilibrium between receptor and ligand in the
environment, and receptor desensitization was modeled using the approach of Lin and
Butcher58 (see Supplemental Text, ESI).
Cells
Peripheral blood mononuclear cells (PBMCs) were isolated by ficoll gradients from
unpurified buffycoats of healthy anonymous donors (Research Blood Components, Boston,
MA). Resting T-cells were isolated by magnetic sorting (pan human T-cell negative
selection kit, Miltenyi, Auburn, CA) and cultured in RPMI-glutamax (Invitrogen, Carlsbad,
CA) containing 10 mM HEPES and 10% fetal calf serum (FCS) for 18 hr prior to use.
Activated T-cells were prepared by stimulating PBMCs with 1 μg/ml PHA for 2 days. On
day 3, stimulated PBMCS were ficolled to remove dead cells, followed by magnetic sorting
of T-cells and culture for 1 day with 100 U/ml IL-2 (Chiron, Emeryville, CA) before use on
day 4. To prepare dendritic cells (DCs), monocytes were isolated from PBMCs by magnetic
selection (CD14 positive selection kit, Miltenyi) and cultured with 25 ng/ml IL-4
(Peprotech, Rocky Hill, NJ) and 100 ng/ml GM-CSF (R&D systems, Minneapolis, MN) for
7 d to generate monocyte-derived DCs. Medium was changed every other day; on day 5, 100
ng/ml LPS was added to mature the DCs, and the cells were used for experiments on day 7.
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Cells used for imaging were labeled with 2.5 μM CMTPX tracer dye (Invitrogen) prior to
experiments according to the manufacturer’s instructions.
Videomicroscopy chemotaxis assay
Alginate bead CRMs with a mean size of ~30 μm diam. were prepared and loaded with
chemokine by adsorption from concentrated attractant solutions just before use as previously
described.40 For some experiments, 1% Alexafluor 488-conjugated chemokine was included
to fluorescently mark the CRMs. Soluble collagen (PureCol® bovine type I collagen,
Advanced Biomatrix, Tucson, AZ ~3 mg/ml stock acid solution) was mixed with 0.1 M
sterile NaOH and 10X phenol red-free RPMI medium in an 8:1:1 vol ratio to achieve pH
7.2, then combined with FCS (final conc. 10% vol/vol) and phenol red-free RPMI at a ratio
of 3:0.33:0.67 to obtain a final collagen concentration of 1.8 mg/ml. Collagen solution
mixed with CMTPX-labeled cells (final conc. 3×106 cells/ml) and chemokine-loaded CRMs
was deposited into pre-heated chambered coverglasses (Nalge Nunc Labtek, Rochester, NY)
and immediately placed in a 5% CO2, 37°C humidified environmental chamber on a Zeiss
Axiovert 200 inverted fluorescence microscope. Fields of view containing single or multiple
CRMs were selected and imaged in time-lapse at 20X. A brightfield image and an 80 μm red
fluorescence z-stack with 4.2 μm z-step size was collected every 1 min (5 min for DCs) for
up to 10 hrs. 80 μm z-stack green fluorescence images were taken before and after time-
lapses to indicate the location of the CRM microspheres.
Single-cell migration analysis
Single cell migration paths from the imaging data were tracked in 3D for the time window
indicated in the text using Volocity 5.2 (PerkinElmer, Waltham, MA). The hit rate, Kon, was
defined as the number of T-cells migrating into contact with a particle per unit time
normalized by the total number of cells in the imaging volume Ntot:12
By taking a ratio of Kon to the theoretical hit rate for lymphocytes encountering CRMs by
chance during random migration through the matrix, Konrand, we obtained a convenient
measure of the degree of directional migration, with Kon/Konrand > 1 indicating biased
migration toward the chemokine sources. Konrand was calculated using a simple 3D random
collision model as previously derived:71
where rT is the radius of the CRM, rM is the contact radius of a cell touching the CRM
surface (15 μm) and vT is the average velocity of the cells.
As further measures characterizing cell migration responses, we calculated: (i) velocity of
the cells; (ii) approach angle, the angle between a vector from the cell to the nearest CRM
and the vector of cell movement at a given time step, (0o for a cell moving directly along the
gradient, 90o perpendicular to the gradient and 180o perfectly antiparallel to the gradient);
(iii) turning angle, the angle between subsequent displacement vectors from two sequential
time steps; and (iv) The instantaneous chemotactic index (ICI), defined as the displacement
of each cell in the direction of the attractant gradient divided by the total path length traveled
over a single observation interval (1 min for T-cells and 5 min for DCs).40,72 ICI values of 1
Wang and Irvine Page 13













reflect migration vectors perfectly aligned with the attractant gradient and -1 perfectly
antiparallel to the gradient; mean values of zero reflect completely random migration. To
capture the effect of differences in the chemoattractant gradient as a function of distance
from the bead, these parameters were binned in 25 μm intervals of distance of the cell from
the bead and the values within each bin were averaged to capture the mean strength of
chemotaxis as a function of position in the gradient over the analysis time: i.e. we averaged
all the values collected for cells 0–25 μm from the CRM, 25–50 μm away, 50–75 μm away,
etc. Cells whose starting positions were beyond 200 μm were binned together and labeled
250 μm. For analysis of beads at higher densities (Figs. 7 and 8), cell paths were analyzed
around clusters of beads that distributed within the collagen gels at approximately uniform
spacing, to account for the lack of precise control on bead spacing. Analyses of cells
swarming around microspheres that departed and were “recaptured” by the gradient were
conducted using Image J (NIH, Bethesda, MD).
Statistical analysis
Measured values are expressed as means ± standard errors (SE). Levels of significance for
comparing groups were using two-tailed nonparametric t-tests. All calculations were made
using GraphPad Prism 5.0.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Physiological chemokine secretion rates produce steady-state CCL19 or CCL21 gradients
that do not saturate responding cell CCR7 receptors and extend up to ~150 μm around
individual source cells. Calculations were made of chemoattractant concentration profiles
developed as a function of radial distance from the secreting cell surface (at r = 0) for
isolated secreting cells (20 μm in diameter) releasing CCL21 or CCL19 at a constant rate.
Shown are the concentration profiles (A), receptor occupancy difference (B), and maximum
stimulation distance rstim (C). (D) Comparison of predicted receptor occupancy gradients for
CCL21 (solid lines) vs. CCL19 (dashed lines) for the noted chemokine secretion rates.
Horizontal dashed lines in B and D show the estimated threshold level of ΔRc required for
directional migration by responding cells.
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Lymphocytes migrating through tissues containing dense arrays of CCL21-secreting cells
should still exhibit localized chemotactic responses near each source cell. (A) 2D schematic
of FEM model, with a regular array of CCL21 sources (20 μm in diam. with a center-to-
center separation of 50–500 μm), showing CCL21 concentration in false color. (B–D)
Predicted profiles of normalized total CCL21 concentration (free and matrix-bound, B),
receptor occupancy (C), and receptor occupancy difference across responding cells (D) as a
function of distance from an individual attractant source in the array, calculated for cells
secreting at 1 pg/cell/hr, including matrix binding sites at a density Cmatrix/Km = 103,
assuming only CCL21 in solution is active for receptor binding.
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Fig. 3. Receptor occupancy gradients predict human leukocyte chemotactic responses toCCL19
vs. CCL21 attractant gradients
CRMs (releasing CCL19 or CCL21 at the indicated rates) and human resting T-cells were
embedded in 3D collagen gels (8×103 beads and 3×106 cells/cm3), and T-cell migration
responses over 30 min were recorded by videomicroscopy. (A–E) Calculated maximum ΔRc
at the surface of CRMs (A, D), hit rate (Kon/Konrand, B, E), and mean T-cell velocities as a
function of chemokinerelease rates (C) for CRMs releasing CCL21 (A–C) or CCL19 (C–E).
(F) Experimental hit rates vs. receptor occupancy gradient. Dashed lines in B, E denote hit
rates expected for random migration; dashed line in C denotes background velocities of T-
cells inthe absence of chemokine. Experimental data are shown as mean ± SE.
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Fig. 4. CRM-generated CCL21 gradients stimulate chemotaxis of resting or activated T-cells
graded by distance of the responding T-cell from the chemokine source
Resting or activated human T-cells were embedded in collagen gels at 3×106 cells/cm3 with
CCL21-CRMs (8×103 beads/cm3, beads loaded with 7.5 μg CCL21/mg alginate) and
imaged by videomicroscopy for 1.5 hr. In parallel, control samples of T-cells and empty
CRMs in collagen mixed with 10 μg/mL “free” CCL21were imaged. (A) Migration
parameters were calculated as averages for all individual cell displacements occurring at a
given distance from the bead (binned in 25 μm intervals) over the 1.5 hr imaging time for
resting T-cells (red, n = 122 cells) or activated T-cells (purple, n = 87 cells) responding to
CCL21-releasing CRMs, or resting T-cells in the presence of empty beads and free CCL21
(blue, n = 61 cells). Shown are mean ± SEM for instantaneous chemotactic index (ICI),
approach angle, turning angle, and normalized velocity. (B) The percentage of time-steps
individual T-cells exhibited ICI values > 0.5 (% time highly chemotactic) was calculated,
and shown are mean values as a function of T-cells’ starting positions in the gradient.
Dashed red line indicates analysis for attracted T-cells only, which migrated into contact
with the CRM during the experiment. (C) Fraction of cells migrating into contact with a
CRM during the observation period as a function of their starting position.
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Fig. 5. Non-desensitizing CCL21 gradients elicit persistent chemotaxis and swarming of
lymphocytes around isolated chemokine sources, while CCL19 gradients elicit transient cell
attraction
Fields of view containing a single central CRM releasing CCL21 (7.5 μg CLL21 per mg
alginate), CCL19 (1 μg CCL19 per mg alginae), or empty beads surrounded by uniform
concentration of free CCL21 (10 μg/mL) were imaged over 6 hr. (A) Path plots of individual
cells around CCL21- or CCL19-releasing CRMs over the first 90 min; dashed circle
indicates the location of chemokine-CRMs; blue solid circle indicates the start of migration
path and red solid circle indicates the end of migration path; grids are 100 μm × 100 μm.(B)
The fraction of T-cells in contact with the surface of the nearby CRM over 6 hr. (C)
Retention time of individual T-cells at the surface of an CRM following initial contact with
the beads. (D–E) The behaviour of “escaping” cells that migrated at least 20 μm away from
the bead surface against CCL21 or CCL19 gradients over 3 hr was characterized: (D) Mean
frequency of escaping T-cells recaptured by the attractant gradients. (E) Histogram of
maximum distance “recaptured” T-cells migrated away from CRM before turning and
returning to the local chemokine source.*, p < 0.05; ***, p < 0.001.
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Fig. 6. Levels of ambient attractant around chemokine sources regulate migration responses to
CCL21
(A) Receptor occupancy gradients at t = 30 min calculated for CCL21-CRMs ((8×103 beads/
cm3, 7.5 μg CCL21 per mg algiante) with surrounding ambient CCL21 concentrations
varying from 10 ng/ml to 1 μg/ml as indicated. (B–D) Migration response of resting T-cells
to CCL21-releasing CRMs in the presence of increasing ambient levels of CCL21 in the
collagen matrix (concentrations as indicated). Shown are hit rate ratios (B), instantaneous
chemotactic indices as a function of distance from the bead surfaces (C), and retention times
of individual T-cells around CCL21-CRMs (D). (E) Fraction of resting T-cells (left) and
activated T-cells (right) trapped around CCL21-CRMs in the presence of ambient
chemokine. *, p< 0.05.
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Fig. 7. Dense chemokine point sources elicit local chemoattraction and “hopping” of resting T-
cells between adjacent sources
Resting human T-cells were embedded in collagen gels with CCL21-CRMs at the indicated
mean center-to-center separations and imaged by videomicroscopy for 1.5 hr. (A) Hit rate of
T-cells migrating into contact with individual CCL21-CRMs as a function of bead
separation. (B) Retention time of cells in contact with individual microspheres. (C)
Representative cell tracks illustrating how individual cells navigated among multiple
CCL21-microspheres. Scale bars 50 μm. (D) Histograms of the number of distinct CRMs
that single cells contact in 60 min, comparing CCL21-CRMs at varied spacing to empty
CRMs in the presence of a uniform field of CCL21 (10 μg/mL). *, p < 0.05; **, p < 0.01.
Wang and Irvine Page 24













Fig. 8. Activated T-cells are trapped by weak localized gradients even in the presence of dense
attractant sources
Activated human T-cells were embedded in collagen gels with CCL21-CRMs (mean bead
separation 100 μm, releasing CCL21 at 0.7 pg/bead/hr) and imaged by videomicroscopy for
3 hr. (A) Representative snapshot of T-cells swarming around closely spaced beads at 30
min (red, T-cells; green, CCL21-CRMs). Scale bar 50 μm. (B) The fraction of T-cells
trapped around 5 different individual beads as well as the total fraction of activated T-cells
trapped around beads in one field of view over time.
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